Abbott Laboratories Pakistan Ltd
Abbott Laboratories Pakistan Ltd operates in Pharmaceuticals.
Abbott Laboratories Pakistan Ltd (ABOT) - Total Assets
Latest total assets as of June 2024: PKRs35.80 Billion PKR
Based on the latest financial reports, Abbott Laboratories Pakistan Ltd (ABOT) holds total assets worth PKRs35.80 Billion PKR as of June 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Abbott Laboratories Pakistan Ltd - Total Assets Trend (2016–2023)
This chart illustrates how Abbott Laboratories Pakistan Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Abbott Laboratories Pakistan Ltd - Asset Composition Analysis
Current Asset Composition (December 2023)
Abbott Laboratories Pakistan Ltd's total assets of PKRs35.80 Billion consist of 63.2% current assets and 36.8% non-current assets.
| Asset Category | Amount (PKR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | PKRs0.00 | 12.4% |
| Accounts Receivable | PKRs1.65 Billion | 4.5% |
| Inventory | PKRs13.29 Billion | 36.2% |
| Property, Plant & Equipment | PKRs0.00 | 0.0% |
| Intangible Assets | PKRs12.68 Million | 0.0% |
| Goodwill | PKRs0.00 | 0.0% |
Asset Composition Trend (2016–2023)
This chart illustrates how Abbott Laboratories Pakistan Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Abbott Laboratories Pakistan Ltd's current assets represent 63.2% of total assets in 2023, a decrease from 74.4% in 2016.
- Cash Position: Cash and equivalents constituted 12.4% of total assets in 2023, down from 46.6% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2016.
- Asset Diversification: The largest asset category is inventory at 36.2% of total assets.
Abbott Laboratories Pakistan Ltd Competitors by Total Assets
Key competitors of Abbott Laboratories Pakistan Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
AGP Ltd
KAR:AGP
|
Pakistan | PKRs28.27 Billion |
|
Sam Chun Dang Pharm. Co. Ltd
KQ:000250
|
Korea | ₩529.96 Billion |
|
DongKoo Bio&Pharma Co. Ltd
KQ:006620
|
Korea | ₩269.00 Billion |
|
NatureCell Co.Ltd
KQ:007390
|
Korea | ₩71.32 Billion |
|
Sam-A Pharm. Co. Ltd
KQ:009300
|
Korea | ₩246.13 Billion |
|
Kyung Dong Pharmaceutical Co. Ltd
KQ:011040
|
Korea | ₩291.47 Billion |
|
WooGene B&G Co. Ltd
KQ:018620
|
Korea | ₩117.10 Billion |
|
Oscotec Inc
KQ:039200
|
Korea | ₩154.14 Billion |
Abbott Laboratories Pakistan Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Abbott Laboratories Pakistan Ltd generates 1.51x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Abbott Laboratories Pakistan Ltd generates $ 0.71 in net profit.
Abbott Laboratories Pakistan Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.65 | 1.33 | 1.74 |
| Quick Ratio | 0.74 | 0.55 | 0.68 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | PKRs8.70 Billion | PKRs 5.88 Billion | PKRs 5.57 Billion |
Abbott Laboratories Pakistan Ltd - Advanced Valuation Insights
This section examines the relationship between Abbott Laboratories Pakistan Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 8.2% |
| Total Assets | PKRs36.69 Billion |
| Market Capitalization | $31.06K USD |
Valuation Analysis
Below Book Valuation: The market values Abbott Laboratories Pakistan Ltd's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Abbott Laboratories Pakistan Ltd's assets grew by 8.2% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Abbott Laboratories Pakistan Ltd (2016–2023)
The table below shows the annual total assets of Abbott Laboratories Pakistan Ltd from 2016 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | PKRs36.69 Billion | +8.18% |
| 2022-12-31 | PKRs33.92 Billion | +18.73% |
| 2021-12-31 | PKRs28.57 Billion | +14.66% |
| 2020-12-31 | PKRs24.92 Billion | +20.06% |
| 2019-12-31 | PKRs20.75 Billion | +2.32% |
| 2018-12-31 | PKRs20.28 Billion | +5.43% |
| 2017-12-31 | PKRs19.24 Billion | +9.02% |
| 2016-12-31 | PKRs17.65 Billion | -- |